Skip to content
Flyout Menu
About Us
Overview
The Sai Way
Leadership
Quality
Facilities
Boston
Manchester
Hyderabad
Bidar
Our Capabilities
Discovery
CADD & Structural Biology
Compound Management
DMPK (Drug Metabolism & Pharmacokinetics)
In Vitro Biology
In Vivo Pharmacology
Integrated Drug Discovery (IDD)
Safety & Toxicology
Synthetic & Medicinal Chemistry
Drug Substance Development
Analytical Development
Developability & Pre-Formulation
Particle Science & Engineering
Process Development
Process Engineering
Discovery Process Chemistry
Drug Substance Manufacturing
Engineering Technologies
Infrastructure
Product Types
New Modalities
Antibody–Drug Conjugates
Lipids
Oligos
Peptides
Formulations
Clinical Formulation Supplies
New Chemical Entity (NCE) formulation development
Responsibility
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Knowledge Hub
Newsroom
Newsroom – Blogs
Newsroom – Case Studies
Investors
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Careers
Contact us
About Us
Overview
The Sai Way
Leadership
Quality
Facilities
– Boston
– Manchester
– Hyderabad
– Bidar
Overview
The Sai Way
Leadership
Quality
Facilities
– Boston
– Manchester
– Hyderabad
– Bidar
Our Capabilities
Discovery
Integrated Drug Discovery (IDD)
CADD & Structural Biology
Synthetic & Medicinal Chemistry
In Vitro Biology
DMPK (Drug Metabolism & Pharmacokinetics)
In Vivo Pharmacology
Safety & Toxicology
Compound Management
Discovery
Integrated Drug Discovery (IDD)
CADD & Structural Biology
Synthetic & Medicinal Chemistry
In Vitro Biology
DMPK (Drug Metabolism & Pharmacokinetics)
In Vivo Pharmacology
Safety & Toxicology
Compound Management
Drug Substance Development
Discovery Process Chemistry
Process Development
Analytical Development
Process Engineering
Particle Science & Engineering
Developability & Pre-Formulation
Drug Substance Development
Discovery Process Chemistry
Process Development
Analytical Development
Process Engineering
Particle Science & Engineering
Developability & Pre-Formulation
Drug Substance Manufacturing
Product Types
Infrastructure
Engineering Technologies
Formulations
New Chemical Entity (NCE) formulation development
Clinical Formulation Supplies
Drug Substance Manufacturing
Product Types
Infrastructure
Engineering Technologies
Formulations
New Chemical Entity (NCE) formulation development
Clinical Formulation Supplies
New Modalities
Antibody–Drug Conjugates
Peptides
Oligos
New Modalities
Antibody–Drug Conjugates
Peptides
Oligos
Responsibility
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Knowledge Hub
Newsroom
Blogs
Case Studies
Newsroom
Blogs
Case Studies
Investors
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Careers
Contact us
About Us
Overview
The Sai Way
Leadership
Quality
Facilities
– Boston
– Manchester
– Hyderabad
– Bidar
Overview
The Sai Way
Leadership
Quality
Facilities
– Boston
– Manchester
– Hyderabad
– Bidar
Our Capabilities
Discovery
Integrated Drug Discovery (IDD)
CADD & Structural Biology
Synthetic & Medicinal Chemistry
In Vitro Biology
DMPK (Drug Metabolism & Pharmacokinetics)
In Vivo Pharmacology
Safety & Toxicology
Compound Management
Discovery
Integrated Drug Discovery (IDD)
CADD & Structural Biology
Synthetic & Medicinal Chemistry
In Vitro Biology
DMPK (Drug Metabolism & Pharmacokinetics)
In Vivo Pharmacology
Safety & Toxicology
Compound Management
Drug Substance Development
Discovery Process Chemistry
Process Development
Analytical Development
Process Engineering
Particle Science & Engineering
Developability & Pre-Formulation
Drug Substance Development
Discovery Process Chemistry
Process Development
Analytical Development
Process Engineering
Particle Science & Engineering
Developability & Pre-Formulation
Drug Substance Manufacturing
Product Types
Infrastructure
Engineering Technologies
Formulations
New Chemical Entity (NCE) formulation development
Clinical Formulation Supplies
Drug Substance Manufacturing
Product Types
Infrastructure
Engineering Technologies
Formulations
New Chemical Entity (NCE) formulation development
Clinical Formulation Supplies
New Modalities
Antibody–Drug Conjugates
Peptides
Oligos
New Modalities
Antibody–Drug Conjugates
Peptides
Oligos
Responsibility
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Knowledge Hub
Newsroom
Blogs
Case Studies
Newsroom
Blogs
Case Studies
Investors
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Careers
Contact us
About Us
Main Menu
Overview
The Sai Way
Leadership
Quality
Facilities
Boston
Manchester
Hyderabad
Bidar
Our Capabilities
Main Menu
Discovery
Integrated Drug Discovery (IDD)
CADD & Structural Biology
Synthetic & Medicinal Chemistry
In Vitro Biology
DMPK (Drug Metabolism & Pharmacokinetics)
In Vivo Pharmacology
Safety & Toxicology
Compound Management
Drug Substance Development
Discovery Process Chemistry
Process Development
Analytical Development
Process Engineering
Particle Science & Engineering
Developability & Pre-Formulation
Drug Substance Manufacturing
Product Types
Infrastructure
Engineering Technologies
Formulations
New Chemical Entity (NCE) formulation development
Clinical Formulation Supplies
New Modalities
Antibody–Drug Conjugates
Peptides
Oligos
Sustainability
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Knowledge Hub
Newsroom
Blogs
Case Studies
Newsroom
Blogs
Case Studies
Investors
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Careers
Contact us
About Us
Main Menu
Overview
The Sai Way
Leadership
Quality
Facilities
Boston
Manchester
Hyderabad
Bidar
Our Capabilities
Main Menu
Discovery
Integrated Drug Discovery (IDD)
CADD & Structural Biology
Synthetic & Medicinal Chemistry
In Vitro Biology
DMPK (Drug Metabolism & Pharmacokinetics)
In Vivo Pharmacology
Safety & Toxicology
Compound Management
Drug Substance Development
Discovery Process Chemistry
Process Development
Analytical Development
Process Engineering
Particle Science & Engineering
Developability & Pre-Formulation
Drug Substance Manufacturing
Product Types
Infrastructure
Engineering Technologies
Formulations
New Chemical Entity (NCE) formulation development
Clinical Formulation Supplies
New Modalities
Antibody–Drug Conjugates
Peptides
Oligos
Sustainability
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Sustainability
Health, Safety and Environment
Corporate Social Responsibility
Knowledge Hub
Newsroom
Blogs
Case Studies
Newsroom
Blogs
Case Studies
Investors
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Investor Relations
Financial Information
Annual reports
Corporate Governance
Shareholder Services
Disclosures
Careers
Contact us
Target Validation to Your Lead Candidate
By
Sundeep Mallipudi
/
August 19, 2025
Previous
Lead identified to First-in-Human Trials
